Immune Deficiency Diseases

Overview

Robert Kellar distinguishes primary immune deficiencies—usually inherited, single-gene defects—from secondary deficiencies acquired through conditions such as malnutrition, medical treatment, or HIV infection. He traces how B-cell defects such as X-linked agammaglobulinemia, thymic defects such as DiGeorge syndrome, and combined deficiencies such as ADA-related SCID impair immune defense, then explains how HIV infects CD4 helper T cells, can remain latent for years, and may progress to AIDS and opportunistic disease.

Key takeaways

Primary immune deficiencies are inherited defects, often involving a single gene, while secondary deficiencies result from later influences such as malnutrition, chemotherapy, or HIV.
Bruton disease blocks B-cell maturation, whereas IgA deficiency selectively reduces an antibody important at mucosal surfaces and is linked to recurrent sinus, respiratory, and gastrointestinal infections.
A defective thymus in DiGeorge syndrome disrupts T-cell maturation, potentially reducing both CD4 helper and CD8 cytotoxic T-cell function.
ADA-related SCID can prevent mature B- and T-cell development; the same immune-cell deficit makes SCID mice useful for studying transplanted human cells.
HIV binds CD4 and uses CCR5 as a co-receptor to enter helper T cells, then integrates viral DNA into the host genome; CCR5-Δ32 can resist infection by CCR5-using strains.
HIV may remain clinically latent for years before renewed replication depletes CD4 cells, leading to AIDS and increased vulnerability to opportunistic infections.

Chapters

0:00 Primary Immune Deficiencies: Inherited Defects in Immune-Cell Development

Primary deficiencies are generally congenital and associated with single-gene defects; secondary deficiencies develop after birth.
The lecture groups primary defects by impaired B-cell, T-cell, combined B- and T-cell, complement, or phagocyte function.
Knowing what complement and phagocytes normally do helps predict the consequences of defects in inflammation or debris clearance.

4:53 B-Cell Deficiencies: Bruton Disease and IgA Deficiency

X-linked agammaglobulinemia, also called Bruton disease, prevents patients—most often males—from developing mature B cells while T-cell responses remain relatively normal.
Without mature B cells and memory B cells, antibody-mediated protection is impaired and exposures may repeatedly resemble a first encounter.
Selective IgA deficiency is described as the most common primary immune deficiency; reduced IgA weakens protection at mucosal surfaces and is associated with recurrent sinus, respiratory, and gastrointestinal infections.
IgA-deficient patients may also have increased atopy, autoimmune disease, and susceptibility to some cancers.

8:51 DiGeorge Syndrome: T-Cell Development Depends on the Thymus

DiGeorge syndrome can involve a nonfunctional thymus, where bone-marrow-derived T-cell precursors normally mature.
Without effective thymic development and central tolerance, functional T-cell populations are reduced.
Both CD4 helper T cells and CD8 cytotoxic T cells can be affected, weakening multiple arms of adaptive immunity.

10:40 ADA-Related SCID and Why Antihistamines Relieve Allergies

Severe combined immunodeficiency (SCID) can prevent mature B- and T-cell development; adenosine deaminase (ADA) deficiency is one cause.
David Vetter, known as the “bubble boy,” lived in protective isolation because ordinary infections could be life-threatening with SCID.
SCID mice, which lack functional B and T cells, can serve as hosts for xenogenic transfer experiments involving human cells.
In IgE-mediated type I hypersensitivity, histamine drives allergic symptoms; diphenhydramine (Benadryl) blocks histamine, while loratadine (Claritin) is a less-sedating antihistamine.

14:55 Secondary Immunodeficiency: Malnutrition, Stress, and Medical Treatment

Secondary immune deficiencies arise from other conditions or exposures rather than inherited immune-system defects.
Malnutrition, including inadequate dietary zinc, can impair B- and T-cell production; stress-related glucocorticoids can suppress immune activity.
Iatrogenic bone-marrow suppression can follow cancer treatments such as chemotherapy or radiation, reducing the source of immune cells.
An active infection can divert resources toward fighting that infection and temporarily reduce readiness against other threats.

17:03 HIV Infection: CD4 Targeting, Latency, and Progression to AIDS

HIV is an acquired cause of immunodeficiency; transmission can occur through sexual contact, blood exposure including shared injection equipment, or maternal-fetal transfer.
As an enveloped retrovirus, HIV uses reverse transcriptase to convert its RNA into DNA and integrate it into host cells; gp120 binds CD4, with CCR5 serving as a key co-receptor for entry.
The CCR5-Δ32 mutation can confer strong resistance to infection by CCR5-using HIV strains, making CCR5 a significant research target.
After an acute rise in viremia, HIV may enter clinical latency lasting months or years; later viral replication depletes CD4 helper T cells and can progress to AIDS.
AIDS leaves patients vulnerable to opportunistic diseases that a functioning immune system would normally control; HIV-1 is more prevalent in the United States, Europe, and Central Africa, while HIV-2 is more common in West Africa.

Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Robert Kellar, Ph.D..